Preliminary results from an ongoing observational study in Botswana found that women who took dolutegravir — the active ingredient in Juluca — when they became pregnant, or early in the first trimester of pregnancy, were at an increased risk of giving birth to babies with neural tube defects, according to the FDA.
Free Confidential Lawsuit Evaluation: If your child or other loved one was born with a birth defect after the mother took Juluca in pregnancy, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
Neural tube defects are characterized as birth defects occurring in the brain, spine, or spinal cord. They initially develop during the first trimester of pregnancy, in many cases before a woman even knows she’s pregnant. The 2 most commonly reported neural tube defects are spina bifida and anencephaly.
Juluca (generic: dolutegravir) is the first complete treatment regimen that contains only two drugs to treat human immunodeficiency virus type 1 (HIV-1), according to the FDA. It contains the following medicines combined in one pill:
- Dolutegravir – an HIV medicine called an integrase inhibitor
- Rilpivirine – an HIV medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI)
Juluca is intended to treat adults with HIV-1 infections whose virus is currently suppressed for a minimum of 6 months, who have no history of treatment failure and no known substitutions associated with resistance to ingredients in the drug.
FDA is advising patients who are already taking Juluca not to discontinue treatment without talking to their doctor. Doing so could worsen their HIV infection, the agency says.
In patients who are pregnant or who may become pregnant, quitting Juluca without switching to another HIV drug could cause the virus to increase and spread to the baby.
If you take Juluca at the time of becoming pregnant and/or during the first trimester of pregnancy, there is a risk that your baby may develop neural tube defects. These types of abnormalities initially develop very early in pregnancy, before many women even know they are pregnant. For this reason, women of childbearing age should talk to their doctor about alternative HIV treatments, FDA said.
Can I File a Juluca Lawsuit?
Only a qualified attorney can determine whether you are eligible to file a lawsuit against ViiV Healthcare, the maker of Juluca, which is why we are currently offering free case evaluations. Simply fill out the confidential evaluation form below to contact our law firm now.
Most cases involving pharmaceuticals allege that a drug was sold with design, manufacturing, and/or marketing defects, which typically refers to a company’s failure to warn of a certain side effect. In the case of Juluca, our attorneys suspect that patients may be able to take legal action in light of claims that Viiv failed to adequately warn doctors and patients about the risk of birth defects.
How Can Filing a Lawsuit Help Me?
By filing a lawsuit against the maker of Juluca, you may be entitled to collect compensation for all current and future medical expenses related to the treatment of your child’s neural tube defect, as well as for damages for pain and suffering. Additionally, filing a lawsuit can help hold the drug’s manufacturer accountable for releasing an allegedly defective drug into the marketplace, and to discourage other pharmaceutical companies from engaging in similar conduct.
Do I have a Juluca Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Juluca lawsuits. We are handling individual litigation nationwide and currently accepting new neural tube birth defect cases in all 50 states.
Free Case Evaluation: Again, if your child was harmed by the side effects of Julica, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.